Question 1

Does Avoro Capital Advisors own XENE stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Avoro Capital Advisors holds 5,777,777 shares of XENE (Xenon Pharmaceuticals), worth $348.7M.

Question 2

How many shares of XENE does Avoro Capital Advisors own?

Accepted Answer

As of its Q2 2026 13F, Avoro Capital Advisors holds 5,777,777 shares of XENE (Xenon Pharmaceuticals).

Question 3

What is Avoro Capital Advisors' XENE position worth?

Accepted Answer

As of its Q2 2026 13F, Avoro Capital Advisors' XENE position is worth $348.7M.

Question 4

When did Avoro Capital Advisors first buy XENE?

Accepted Answer

Avoro Capital Advisors already held XENE in its Q1 2019 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Unchanged	5.8M	0.0%	$348.7M	3.1%	$60.36	0
2026-Q1	Increased	5.8M	+6.5%	$336M	3.3%	$43.79	62
2025-Q4	Increased	5.4M	+0.5%	$243.1M	2.4%	$44.12	54
2025-Q3	Unchanged	5.4M	0.0%	$216.8M	2.8%	$39.06	0
2025-Q2	Decreased	5.4M	-6.0%	$169M	3.0%	$32.40	0
2025-Q1	Increased	5.7M	+1.3%	$192.6M	3.0%	$34.26	58
2024-Q4	Unchanged	5.7M	0.0%	$222.1M	3.1%	$38.53	0
2024-Q3	Unchanged	5.7M	0.0%	$223.1M	3.3%	$38.65	0